Critical study of crop-derived biochars for soil amendment and pharmaceutical ecotoxicity reduction.

In this study, biochars (BCs) produced from crops (straw and seeds) were tested for the applicability as additive to soils. The effect on pH, water capacity and cation exchange capacity of soil were tested. The ability for the sorption of pharmaceuticals (beta-blockers, anti-inflammatory drugs, sulfonamides, 17α-ethinylestradiol, carbamazepine, caffeine) using the batch sorption test was performed, and the effect of water pH was investigated. In addition, the metals removed from the biochar was analyzed as a potential toxicity factor. The mechanism of adsorption (Langmuir, Freundlich) was tested for sulfadimetoxine. The effect of the rye-derived biochar on water cress germination and the reduction of the sulfonamides toxicity to this plant was tested. The advantages of crop-derived biochar application to different soils (sand soil, clay soil and reference soil) was presented. It was found that tested BCs effectively increase the water capacity of soils, especially sand type soil, but in the same time it had increase the pH of pure-buffering soils. The driving force of pharmaceutical sorption was its ionization form - the highest sorption occurs for cations, medium for neutral forms, while the lowest sorption for anions. The opposite situation have been noted for desorption from biochar. The washing of biochars increases sorption for the neutral and anionic species, but not for the cations. The application of biochars into the soils can from one site protect the plants from toxic impact of sulfonamides, but from the other hamper the root prolongation by the pH increase.

Ionic liquids for the passive sampling of sulfonamides from water-applicability and selectivity study.

Ionic liquids (ILs) are new-generation, non-volatile solvents which are designable, and their structure may be specifically adjusted to the current application needs. Therefore, it is possible to create and apply ILs which efficiently and selectively extract various analytes from different matrices. It has already been examined that ILs may be applied as receiving phases in passive sampling for the long-term water monitoring of PAHs and pharmaceuticals in water. In this paper, the concept of passive sampling with ILs (PASSIL applied as receiving phases) was continued and developed using phosphonium-, imidazolium-, and morpholinium-cation-based ILs. The target group of analytes was pharmaceuticals which represent one of the most common categories of water contaminants. Fourteen-day-long extractions using various ILs were performed in stirred conditions at a constant temperature (20 °C). The best extraction efficiency was achieved for trihexyl(tetradecyl)phosphonium dicyanamide ([P666-14][N(CN)2]). For this preliminary calibration, the sampling rates were calculated for each sulfonamide. Once again, selectivity was observed in passive sampling using [P666-14][N(CN)2]. Therefore, PASSIL is seen as a very promising method for pharmaceutical monitoring in water.

Calibration of Passive Samplers for the Monitoring of Pharmaceuticals in Water-Sampling Rate Variation.

Passive sampling is one of the most efficient methods of monitoring pharmaceuticals in environmental water. The reliability of the process relies on a correctly performed calibration experiment and a well-defined sampling rate (Rs) for target analytes. Therefore, in this review the state-of-the-art methods of passive sampler calibration for the most popular pharmaceuticals: antibiotics, hormones, ß-blockers and non-steroidal anti-inflammatory drugs (NSAIDs), along with the sampling rate variation, were presented. The advantages and difficulties in laboratory and field calibration were pointed out, according to the needs of control of the exact conditions. Sampling rate calculating equations and all the factors affecting the Rs value - temperature, flow, pH, salinity of the donor phase and biofouling - were discussed. Moreover, various calibration parameters gathered from the literature published in the last 16 years, including the device types, were tabled and compared. What is evident is that the sampling rate values for pharmaceuticals are impacted by several factors, whose influence is still unclear and unpredictable, while there is a big gap in experimental data. It appears that the calibration procedure needs to be improved, for example, there is a significant deficiency of PRCs (Performance Reference Compounds) for pharmaceuticals. One of the suggestions is to introduce correction factors for Rs values estimated in laboratory conditions.